Valuation: Stratec SE

Market Cap 26Cr 30Cr 24Cr 22Cr 42Cr 2.89TCr 42Cr 285.96Cr 111.97Cr 1.45TCr 113.6Cr 111.13Cr 4.8TCr P/E 2026 *
19.1x
P/E 2027 * 14.2x
Enterprise Value 35Cr 41Cr 33Cr 30Cr 57Cr 3.92TCr 58Cr 387.57Cr 151.77Cr 1.97TCr 153.97Cr 150.62Cr 6.5TCr EV / Sales 2026 *
1.34x
EV / Sales 2027 * 1.26x
Free-Float
39.08%
Yield 2026 *
3.04%
Yield 2027 * 3.61%
1 day-4.68%
1 week+5.96%
Current month+8.49%
1 month+12.13%
3 months+25.29%
6 months+2.64%
Current year-3.61%
1 week 20.1
Extreme 20.1
23.05
1 month 18.58
Extreme 18.58
23.05
Current year 16.38
Extreme 16.38
23.9
1 year 16.38
Extreme 16.38
32.2
3 years 16.38
Extreme 16.38
50.6
5 years 16.38
Extreme 16.38
144.8
10 years 16.38
Extreme 16.38
145.2
Manager TitleAgeSince
Chief Executive Officer 59 01/04/2011
Director of Finance/CFO 38 01/11/2025
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 29/05/2019
Director/Board Member 73 21/07/2020
Chairman 68 20/05/2022
Change 5-day change 1-year change 3-year change Capi.($)
-4.90%+5.96% - - 30Cr
+4.16%+1.75%+23.13%+15.27% 22TCr
+5.97%+2.77%-0.33%-15.46% 14TCr
+1.67%-0.88%-17.00%+38.74% 14TCr
+3.05%+1.15%-49.87%+3.15% 7.31TCr
+1.43%-0.83%+16.91%+20.90% 5.24TCr
+1.32%+0.99%-15.35%-12.15% 5.09TCr
+4.70%+4.84%+29.39%+30.75% 4.19TCr
+3.64%-0.07%+39.67%+55.65% 3.94TCr
+2.74%+3.24%+0.88%+8.19% 3.28TCr
Average +2.44%-1.97%+3.05%+16.12% 8.74TCr
Weighted average by Cap. +3.60%-2.40%+2.45%+13.94%

Financials

2026 *2027 *
Net sales 26Cr 31Cr 24Cr 22Cr 42Cr 2.92TCr 43Cr 288.66Cr 113.03Cr 1.46TCr 114.68Cr 112.18Cr 4.84TCr 28Cr 33Cr 26Cr 24Cr 46Cr 3.16TCr 46Cr 312.13Cr 122.22Cr 1.58TCr 124Cr 121.3Cr 5.23TCr
Net income 1.38Cr 1.61Cr 1.29Cr 1.18Cr 2.23Cr 153.94Cr 2.26Cr 15Cr 5.96Cr 77Cr 6.05Cr 5.92Cr 255.26Cr 1.82Cr 2.13Cr 1.7Cr 1.56Cr 2.94Cr 203.15Cr 2.99Cr 20Cr 7.87Cr 101.88Cr 7.98Cr 7.81Cr 336.87Cr
Net Debt 9.22Cr 11Cr 8.61Cr 7.9Cr 15Cr 1.03TCr 15Cr 101.62Cr 40Cr 515.39Cr 40Cr 39Cr 1.7TCr 9.62Cr 11Cr 8.98Cr 8.24Cr 15Cr 1.07TCr 16Cr 105.99Cr 42Cr 537.56Cr 42Cr 41Cr 1.78TCr
Logo Stratec SE
Stratec SE is a Germany-based company. The Company is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. It also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
Employees
1,395
Date Price Change Volume
19/26/19 21.35 -4.90% 0
18/26/18 €22.45 -2.39% 0
17/26/17 €23.00 +3.84% 153
14/26/14 €22.15 +10.20% 800
13/26/13 €20.10 +0.25% 0
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
21.35EUR
Average target price
25.60EUR
Spread / Average Target
+19.91%

Quarterly revenue - Rate of surprise